Delivery Order SPE2DB20D1047-SPE2DB25FF35K

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,276.83 firm fixed-price delivery order is for the supply of Repatha 420 mg/3.5 ml PushTronX 3.5 ml, a specialty medication. The contract has an ultimate completion date of August 28, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,046.51 firm fixed-price delivery order is for the supply of Repatha 420 mg/3.5 ml Pushtronx 3.5 ml, a specialty medication. The contract has an ultimate completion date of May 15, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,277.52 delivery order contract is for the supply of the prescription medication Repatha 420 mg/3.5 ml Pushtronx 3.5 ml. The contract has a firm-fixed price and a completion date of August 30, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB22D2005|SPE2DB24FJNW9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $6,215.95, is for the delivery of the drug Repatha (140 mg/mL) and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $5,461.29, is for the delivery of Repatha 420 mg/3.5 ml PushTronX 3.5 ml, a prescription medication. This is a firm fixed-price delivery order contract, with a completion date of May 7, 2024. Amerisourcebergen Drug Corp, which is a subsidiary of Amerisourcebergen Corporation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the specialty medication Repatha 420 mg/3.5 ml Pushtronx 3.5 ml. The $2,915.54 firm fixed-price delivery order has an ultimate completion date of August 22, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,358.40 delivery order contract is for the supply of Repatha 140 mg/mL SureClick injection medication. The contract has a firm fixed price pricing type and an ultimate completion date of February 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D1004|SPE2DB24FF1R2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,033.64 firm fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick medication, with a period of performance through January 5, 2024. The contract is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMDHQ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,683.61 firm fixed-price delivery order is for the specialty drug Repatha (140 mg/mL) and has an ultimate completion date of December 4, 2024. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of the medication Repatha (140 mg/ml SureClick) to the Defense Logistics Agency (DLA). The Delivery Order is valued at $4,207.92 and has a firm fixed price. The contract has an ultimate completion date of December 16, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated with any set-aside requirements, indicating open competition. The...
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB25FF35K
    Delivery Order

This federal contract award, with an ID of SPE2DB20D1047|SPE2DB25FF35K, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,056.86, is for the delivery of the drug Repatha, a 420 mg/3.5 ml Pushtronx injection. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 6, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, the prime contractor, provides a broad range of pharmaceutical products and medical supplies to support federal healthcare programs, particularly within the military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/4/25, 10:05 AM